Science 7 June 1985: Vol. 228. no. 4704, pp. 1201 - 1204 DOI: 10.1126/science.3159089

Prev | Table of Contents | Next

Articles

A macaque model of HIV-1 infection.

T. Hatziioannou, Z. Ambrose, N. P. Y. Chung, M. Piatak Jr., F. Yuan, C. M. Trubey, V. Coalter, R. Kiser, D. Schneider, J. Smedley, et al. (2009)
PNAS 106, 4425-4429
 |  Abstract »  |  Full Text »  |  PDF »

Increased Loss of CCR5+ CD45RA- CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys.

R. S. Veazey, P. M. Acierno, K. J. McEvers, S. H. C. Baumeister, G. J. Foster, M. D. Rett, M. H. Newberg, M. J. Kuroda, K. Williams, E.-Y. Kim, et al. (2008)
J. Virol. 82, 5618-5630
 |  Abstract »  |  Full Text »  |  PDF »

Unique Pathology in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques Is Consistent with a Pathogenesis Distinct from That of Classical AIDS.

C. R. Brown, M. Czapiga, J. Kabat, Q. Dang, I. Ourmanov, Y. Nishimura, M. A. Martin, and V. M. Hirsch (2007)
J. Virol. 81, 5594-5606
 |  Abstract »  |  Full Text »  |  PDF »

Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses.

S. VandeWoude and C. Apetrei (2006)
Clin. Microbiol. Rev. 19, 728-762
 |  Abstract »  |  Full Text »  |  PDF »

Transmission of Simian Immunodeficiency Virus SIVcpz and the Evolution of Infection in the Presence and Absence of Concurrent Human Immunodeficiency Virus Type 1 Infection in Chimpanzees.

J. L. Heeney, E. Rutjens, E. J. Verschoor, H. Niphuis, P. ten Haaft, S. Rouse, H. McClure, S. Balla-Jhagjhoorsingh, W. Bogers, M. Salas, et al. (2006)
J. Virol. 80, 7208-7218
 |  Abstract »  |  Full Text »  |  PDF »

The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus.

R. Dunham, P. Pagliardini, S. Gordon, B. Sumpter, J. Engram, A. Moanna, M. Paiardini, J. N. Mandl, B. Lawson, S. Garg, et al. (2006)
Blood 108, 209-217
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 Primary Isolates by Gag-Env Pseudovirion Immunization.

J. Hammonds, X. Chen, T. Fouts, A. DeVico, D. Montefiori, and P. Spearman (2005)
J. Virol. 79, 14804-14814
 |  Abstract »  |  Full Text »  |  PDF »

Immunodeficiency in the Absence of High Viral Load in Pig-Tailed Macaques Infected with Simian Immunodeficiency Virus SIVsun or SIVlhoest.

B. E. Beer, C. R. Brown, S. Whitted, S. Goldstein, R. Goeken, R. Plishka, A. Buckler-White, and V. M. Hirsch (2005)
J. Virol. 79, 14044-14056
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm.

C. Apetrei, A. Kaur, N. W. Lerche, M. Metzger, I. Pandrea, J. Hardcastle, S. Falkenstein, R. Bohm, J. Koehler, V. Traina-Dorge, et al. (2005)
J. Virol. 79, 8991-9005
 |  Abstract »  |  Full Text »  |  PDF »

The B30.2(SPRY) Domain of the Retroviral Restriction Factor TRIM5{alpha} Exhibits Lineage-Specific Length and Sequence Variation in Primates.

B. Song, B. Gold, C. O'hUigin, H. Javanbakht, X. Li, M. Stremlau, C. Winkler, M. Dean, and J. Sodroski (2005)
J. Virol. 79, 6111-6121
 |  Abstract »  |  Full Text »  |  PDF »

Retrovirus Restriction by TRIM5{alpha} Variants from Old World and New World Primates.

B. Song, H. Javanbakht, M. Perron, D. H. Park, M. Stremlau, and J. Sodroski (2005)
J. Virol. 79, 3930-3937
 |  Abstract »  |  Full Text »  |  PDF »

Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5{alpha} Determines the Potency of Human Immunodeficiency Virus Restriction.

M. Stremlau, M. Perron, S. Welikala, and J. Sodroski (2005)
J. Virol. 79, 3139-3145
 |  Abstract »  |  Full Text »  |  PDF »

Cell Tropism of Simian Immunodeficiency Virus in Culture Is Not Predictive of in Vivo Tropism or Pathogenesis.

J. T. Borda, X. Alvarez, I. Kondova, P. Aye, M. A. Simon, R. C. Desrosiers, and A. A. Lackner (2004)
Am. J. Pathol. 165, 2111-2122
 |  Abstract »  |  Full Text »  |  PDF »

Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection.

J. Balzarini, S. Hatse, K. Vermeire, K. Princen, S. Aquaro, C.-F. Perno, E. De Clercq, H. Egberink, G. Vanden Mooter, W. Peumans, et al. (2004)
Antimicrob. Agents Chemother. 48, 3858-3870
 |  Abstract »  |  Full Text »  |  PDF »

Binding and Susceptibility to Postentry Restriction Factors in Monkey Cells Are Specified by Distinct Regions of the Human Immunodeficiency Virus Type 1 Capsid.

C. M. Owens, B. Song, M. J. Perron, P. C. Yang, M. Stremlau, and J. Sodroski (2004)
J. Virol. 78, 5423-5437
 |  Abstract »  |  Full Text »  |  PDF »

Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression.

A. Muthukumar, A. Wozniakowski, M.-C. Gauduin, M. Paiardini, H. M. McClure, R. P. Johnson, G. Silvestri, and D. L. Sodora (2004)
Blood 103, 973-979
 |  Abstract »  |  Full Text »  |  PDF »

Assorted Mutations in the Envelope Gene of Simian Immunodeficiency Virus Lead to Loss of Neutralization Resistance against Antibodies Representing a Broad Spectrum of Specificities.

W. E. Johnson, H. Sanford, L. Schwall, D. R. Burton, P. W. H. I. Parren, J. E. Robinson, and R. C. Desrosiers (2003)
J. Virol. 77, 9993-10003
 |  Abstract »  |  Full Text »  |  PDF »

Role of Microglial Cells in Selective Replication of Simian Immunodeficiency Virus Genotypes in the Brain.

T. Babas, D. Munoz, J. L. Mankowski, P. M. Tarwater, J. E. Clements, and M. C. Zink (2002)
J. Virol. 77, 208-216
 |  Abstract »  |  Full Text »  |  PDF »

Human and Simian Immunodeficiency Virus Capsid Proteins Are Major Viral Determinants of Early, Postentry Replication Blocks in Simian Cells.

C. M. Owens, P. C. Yang, H. Gottlinger, and J. Sodroski (2002)
J. Virol. 77, 726-731
 |  Abstract »  |  Full Text »  |  PDF »

MHC Class I Alleles Influence Set-Point Viral Load and Survival Time in Simian Immunodeficiency Virus-Infected Rhesus Monkeys.

T. Muhl, M. Krawczak, P. ten Haaft, G. Hunsmann, and U. Sauermann (2002)
J. Immunol. 169, 3438-3446
 |  Abstract »  |  Full Text »  |  PDF »

Human immunodeficiency virus type 2.

J. D. Reeves and R. W. Doms (2002)
J. Gen. Virol. 83, 1253-1265
 |  Full Text »  |  PDF »

A Replication-Competent, Neutralization-Sensitive Variant of Simian Immunodeficiency Virus Lacking 100 Amino Acids of Envelope.

W. E. Johnson, J. Morgan, J. Reitter, B. A. Puffer, S. Czajak, R. W. Doms, and R. C. Desrosiers (2002)
J. Virol. 76, 2075-2086
 |  Abstract »  |  Full Text »  |  PDF »

CD4 Independence of Simian Immunodeficiency Virus Envs Is Associated with Macrophage Tropism, Neutralization Sensitivity, and Attenuated Pathogenicity.

B. A. Puffer, S. Pohlmann, A. L. Edinger, D. Carlin, M. D. Sanchez, J. Reitter, D. D. Watry, H. S. Fox, R. C. Desrosiers, and R. W. Doms (2002)
J. Virol. 76, 2595-2605
 |  Abstract »  |  Full Text »  |  PDF »

The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments.

M. Kim, B. Chen, R. E. Hussey, Y. Chishti, D. Montefiori, J. A. Hoxie, O. Byron, G. Campbell, S. C. Harrison, and E. L. Reinherz (2001)
J. Biol. Chem. 276, 42667-42676
 |  Abstract »  |  Full Text »  |  PDF »

Mutations within the Putative Membrane-Spanning Domain of the Simian Immunodeficiency Virus Transmembrane Glycoprotein Define the Minimal Requirements for Fusion, Incorporation, and Infectivity.

J. T. West, P. B. Johnston, S. R. Dubay, and E. Hunter (2001)
J. Virol. 75, 9601-9612
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Disseminated Mycobacterium avium in Simian AIDS Is Dependent upon Simian Immunodeficiency Virus Strain and Defective Granuloma Formation.

K. G. Mansfield, R. S. Veazey, A. Hancock, A. Carville, M. Elliott, K.-C. Lin, and A. A. Lackner (2001)
Am. J. Pathol. 159, 693-702
 |  Abstract »  |  Full Text »

Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.

L. Walther-Jallow, C. Nilsson, J. Soderlund, P. ten Haaft, B. Makitalo, P. Biberfeld, P. Bottiger, J. Heeney, G. Biberfeld, and R. Thorstensson (2001)
J. Gen. Virol. 82, 1601-1612
 |  Abstract »  |  Full Text »  |  PDF »

Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4.

R. E. Means, T. Matthews, J. A. Hoxie, M. H. Malim, T. Kodama, and R. C. Desrosiers (2001)
J. Virol. 75, 3903-3915
 |  Abstract »  |  Full Text »

Identification of Enteropathogenic Escherichia coli in Simian Immunodeficiency Virus-Infected Infant and Adult Rhesus Macaques.

K. G. Mansfield, K.-C. Lin, J. Newman, D. Schauer, J. MacKey, A. A. Lackner, and A. Carville (2001)
J. Clin. Microbiol. 39, 971-976
 |  Abstract »  |  Full Text »

Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmac{Delta}nef.

E. Khatissian, V. Monceaux, M.-C. Cumont, M.-P. Kieny, A.-M. Aubertin, and B. Hurtrel (2001)
J. Virol. 75, 1507-1515
 |  Abstract »  |  Full Text »

CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing.

T. M. Allen, B. R. Mothé, J. Sidney, P. Jing, J. L. Dzuris, M. E. Liebl, T. U. Vogel, D. H. O'Connor, X. Wang, M. C. Wussow, et al. (2001)
J. Virol. 75, 738-749
 |  Abstract »  |  Full Text »

Simian immunodeficiency virus resistance of macaques infused with interferon {beta}-engineered lymphocytes.

F. Matheux, E. Lauret, V. Rousseau, J. Larghero, B. Boson, B. Vaslin, A. Cheret, E. De Maeyer, D. Dormont, and R. LeGrand (2000)
J. Gen. Virol. 81, 2741-2750
 |  Abstract »  |  Full Text »

Effect of the Cytoplasmic Domain of the Simian Immunodeficiency Virus Envelope Protein on Incorporation of Heterologous Envelope Proteins and Sensitivity to Neutralization.

A. N. Vzorov and R. W. Compans (2000)
J. Virol. 74, 8219-8225
 |  Abstract »  |  Full Text »

Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina).

Z. Chen, Y. Huang, X. Zhao, E. Skulsky, D. Lin, J. Ip, A. Gettie, and D. D. Ho (2000)
J. Virol. 74, 6501-6510
 |  Abstract »  |  Full Text »

Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry.

S. Pöhlmann, B. Lee, S. Meister, M. Krumbiegel, G. Leslie, R. W. Doms, and F. Kirchhoff (2000)
J. Virol. 74, 5075-5082
 |  Abstract »  |  Full Text »

AIDS as a Zoonosis: Scientific and Public Health Implications.

B. H. Hahn, G. M. Shaw, K. M. De, Cock, and P. M. Sharp (2000)
Science 287, 607-614
 |  Abstract »  |  Full Text »

Dilated Cardiomyopathy Associated With Simian AIDS in Nonhuman Primates.

R. P. Shannon, M. A. Simon, M. A. Mathier, Y.-J. Geng, S. Mankad, and A. A. Lackner (2000)
Circulation 101, 185-193
 |  Abstract »  |  Full Text »  |  PDF »

A Putative G Protein-Coupled Receptor, RDC1, Is a Novel Coreceptor for Human and Simian Immunodeficiency Viruses.

N. Shimizu, Y. Soda, K. Kanbe, H.-y. Liu, R. Mukai, T. Kitamura, and H. Hoshino (2000)
J. Virol. 74, 619-626
 |  Abstract »  |  Full Text »

Conserved MHC Class I Peptide Binding Motif Between Humans and Rhesus Macaques.

J. L. Dzuris, J. Sidney, E. Appella, R. W. Chesnut, D. I. Watkins, and A. Sette (2000)
J. Immunol. 164, 283-291
 |  Abstract »  |  Full Text »  |  PDF »

Specific passage of simian immunodeficiency virus fromend-stage disease results in accelerated progression to AIDS in rhesus macaques.

L. Holterman, H. Niphuis, P. J. F. ten Haaft, J. Goudsmit, G. Baskin, and J. L. Heeney (1999)
J. Gen. Virol. 80, 3089-3097
 |  Abstract »  |  Full Text »

Species-Specific, Postentry Barriers to Primate Immunodeficiency Virus Infection.

W. Hofmann, D. Schubert, J. LaBonte, L. Munson, S. Gibson, J. Scammell, P. Ferrigno, and J. Sodroski (1999)
J. Virol. 73, 10020-10028
 |  Abstract »  |  Full Text »

Experimental Infection of Rhesus and Pig-Tailed Macaques with Macaque Rhadinoviruses.

K. G. Mansfield, S. V. Westmoreland, C. D. DeBakker, S. Czajak, A. A. Lackner, and R. C. Desrosiers (1999)
J. Virol. 73, 10320-10328
 |  Abstract »  |  Full Text »

Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge.

M. S. Wyand, K. Manson, D. C. Montefiori, J. D. Lifson, R. P. Johnson, and R. C. Desrosiers (1999)
J. Virol. 73, 8356-8363
 |  Abstract »  |  Full Text »  |  PDF »

Postinoculation PMPA Treatment, but Not Preinoculation Immunomodulatory Therapy, Protects against Development of Acute Disease Induced by the Unique Simian Immunodeficiency Virus SIVsmmPBj.

S. Hodge, J. de Rosayro, A. Glenn, I. C. Ojukwu, S. Dewhurst, H. M. McClure, N. Bischofberger, D. C. Anderson, S. A. Klumpp, and F. J. Novembre (1999)
J. Virol. 73, 8630-8639
 |  Abstract »  |  Full Text »  |  PDF »

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates Infect CD4-Negative Cells via CCR5 and CXCR4: Comparison with HIV-1 and Simian Immunodeficiency Virus and Relevance to Cell Tropism In Vivo.

J. D. Reeves, S. Hibbitts, G. Simmons, A. McKnight, J. M. Azevedo-Pereira, J. Moniz-Pereira, and P. R. Clapham (1999)
J. Virol. 73, 7795-7804
 |  Abstract »  |  Full Text »

Shortening of the Symptom-Free Period in Rhesus Macaques Is Associated with Decreasing Nonsynonymous Variation in the env Variable Regions of Simian Immunodeficiency Virus SIVsm during Passage.

P. J. S. Valli, V. V. Lukashov, J. L. Heeney, and J. Goudsmit (1998)
J. Virol. 72, 7494-7500
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus.

T. M. Allen, J. Sidney, M.-F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, et al. (1998)
J. Immunol. 160, 6062-6071
 |  Abstract »  |  Full Text »  |  PDF »

Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease.

M.-A. Rey-Cuille, J.-L. Berthier, M.-C. Bomsel-Demontoy, Y. Chaduc, L. Montagnier, A. G. Hovanessian, and L. A. Chakrabarti (1998)
J. Virol. 72, 3872-3886
 |  Abstract »  |  Full Text »  |  PDF »

Nucleocapsid and Matrix Protein Contributions to Selective Human Immunodeficiency Virus Type 1 Genomic RNA Packaging.

D. T. K. Poon, G. Li, and A. Aldovini (1998)
J. Virol. 72, 1983-1993
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus.

R. C. Desrosiers, J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. M. Howe, L. O. Arthur, and R. P. Johnson (1998)
J. Virol. 72, 1431-1437
 |  Abstract »  |  Full Text »  |  PDF »

Evolution of a Simian Immunodeficiency Virus Pathogen.

P. Edmonson, M. Murphey-Corb, L. N. Martin, C. Delahunty, J. Heeney, H. Kornfeld, P. R. Donahue, G. H. Learn, L. Hood, and J. I. Mullins (1998)
J. Virol. 72, 405-414
 |  Abstract »  |  Full Text »  |  PDF »

Natural Infection of a Household Pet Red-Capped Mangabey (Cercocebus torquatus torquatus) with a New Simian Immunodeficiency Virus.

M. C. Georges-Courbot, C. Y. Lu, M. Makuwa, P. Telfer, R. Onanga, G. Dubreuil, Z. Chen, S. M. Smith, A. Georges, F. Gao, et al. (1998)
J. Virol. 72, 600-608
 |  Abstract »  |  Full Text »  |  PDF »

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.

T. Baba, Y. Jeong, D Pennick, R Bronson, M. Greene, and R. Ruprecht (1995)
Science 267, 1820-1825
 |  Abstract »  |  PDF »

Infection of a Laboratory Worker with Simian Immunodeficiency Virus.

R. F. Khabbaz, W. Heneine, J. R. George, B. Parekh, T. Rowe, T. Woods, W. M. Switzer, H. M. McClure, M. Murphey-Corb, and T. M. Folks (1994)
N. Engl. J. Med. 330, 172-177
 |  Full Text »

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

M. Daniel, F Kirchhoff, S. Czajak, P. Sehgal, and R. Desrosiers (1992)
Science 258, 1938-1941
 |  Abstract »  |  PDF »

Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein.

T Lehner, L. Bergmeier, C Panagiotidi, L Tao, R Brookes, L. Klavinskis, P Walker, J Walker, R. Ward, L Hussain, et al. (1992)
Science 258, 1365-1369
 |  Abstract »  |  PDF »

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

H Kestler, T Kodama, D Ringler, M Marthas, N Pedersen, A Lackner, D Regier, P Sehgal, M Daniel, N King, et al. (1990)
Science 248, 1109-1112
 |  Abstract »  |  PDF »

Enhancement of SIV infection with soluble receptor molecules.

J. Allan, J Strauss, and D. Buck (1990)
Science 247, 1084-1088
 |  Abstract »  |  PDF »

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses.

P Lusso, F di Marzo Veronese, B Ensoli, G Franchini, C Jemma, S. DeRocco, V. Kalyanaraman, and R. Gallo (1990)
Science 247, 848-852
 |  Abstract »  |  PDF »

The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex.

D. D. Ho, D. E. Bredesen, H. V. Vinters, and E. S. Daar (1989)
Ann Intern Med 111, 400-410
 |  Abstract »  |  PDF »

Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection.

A. S. Fauci, R. C. Gallo, S. Koenig, J. Salk, and R. H. Purcell (1989)
Ann Intern Med 110, 373-385
 |  Abstract »  |  PDF »

Infection of the SCID-hu mouse by HIV-1.

R Namikawa, H Kaneshima, M Lieberman, I. Weissman, and J. McCune (1988)
Science 242, 1684-1686
 |  Abstract »  |  PDF »

Documentation of an AIDS Virus Infection in the United States in 1968.

R. F. Garry, M. H. Witte, A. A. Gottlieb, M. Elvin-Lewis, M. S. Gottlieb, C. L. Witte, S. S. Alexander, W. R. Cole, and W. L. Drake Jr (1988)
JAMA 260, 2085-2087
 |  Abstract »  |  PDF »

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

L. Henderson, R. Sowder, T. Copeland, R. Benveniste, and S Oroszlan (1988)
Science 241, 199-201
 |  Abstract »  |  PDF »

Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats.

J Overbaugh, P. Donahue, S. Quackenbush, E. Hoover, and J. Mullins (1988)
Science 239, 906-910
 |  Abstract »  |  PDF »

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

A. Fauci (1988)
Science 239, 617-622
 |  Abstract »  |  PDF »

A quantitative bioassay for HIV-1 based on trans-activation.

B. Felber and G. Pavlakis (1988)
Science 239, 184-187
 |  Abstract »  |  PDF »

Functional interaction and partial homology between human immunodeficiency virus and neuroleukin.

M. Lee, D. Ho, and M. Gurney (1987)
Science 237, 1047-1051
 |  Abstract »  |  PDF »

The Many Epidemiological Faces of AIDS With Special Reference to Hong Kong and Implications for Prevention and Control.

K. Thong (1987)
Asia Pac J Public Health 1, 17-23
 |  Abstract »  |  PDF »

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.

P. Kanki, S M'Boup, D Ricard, F Barin, F Denis, C Boye, L Sangare, K Travers, M Albaum, R Marlink, et al. (1987)
Science 236, 827-831
 |  Abstract »  |  PDF »

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

N. Pedersen, E. Ho, M. Brown, and J. Yamamoto (1987)
Science 235, 790-793
 |  Abstract »  |  PDF »

AIDS in Africa: an epidemiologic paradigm.

T. Quinn, J. Mann, J. Curran, and P Piot (1986)
Science 234, 955-963
 |  Abstract »  |  PDF »

Isolation of a new human retrovirus from West African patients with AIDS.

F Clavel, D Guetard, F Brun-Vezinet, S Chamaret, M. Rey, M. Santos-Ferreira, A. Laurent, C Dauguet, C Katlama, C Rouzioux, et al. (1986)
Science 233, 343-346
 |  Abstract »  |  PDF »

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

P. Kanki, F Barin, S M'Boup, J. Allan, J. Romet-Lemonne, R Marlink, M. McLane, T. Lee, B Arbeille, F Denis, et al. (1986)
Science 232, 238-243
 |  Abstract »  |  PDF »

Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus.

M. Power, P. Marx, M. Bryant, M. Gardner, P. Barr, and P. Luciw (1986)
Science 231, 1567-1572
 |  Abstract »  |  PDF »

Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys.

P. Kanki, J Alroy, and M Essex (1985)
Science 230, 951-954
 |  Abstract »  |  PDF »

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

J. Allan, J. Coligan, T. Lee, M. McLane, P. Kanki, J. Groopman, and M Essex (1985)
Science 230, 810-813
 |  Abstract »  |  PDF »

Antigens of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus.

M. ESSEX, J. ALLAN, P. KANKI, M. F. McLANE, G. MALONE, L. KITCHEN, and T. H. LEE (1985)
Ann Intern Med 103, 700-703
 |  Abstract »  |  PDF »

Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

N. Letvin, M. Daniel, P. Sehgal, R. Desrosiers, R. Hunt, L. Waldron, J. MacKey, D. Schmidt, L. Chalifoux, and N. King (1985)
Science 230, 71-73
 |  Abstract »  |  PDF »

Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III.

P. Kanki, M. McLane, N. King Jr, N. Letvin, R. Hunt, P Sehgal, M. Daniel, R. Desrosiers, and M Essex (1985)
Science 228, 1199-1201
 |  Abstract »  |  PDF »

To Advertise   |   Find Products